Continue reading this on our app for a better experience

Open in App
Home Capital Broker's Calls

Hyphens Pharma gets a 'buy' from SAC as it looks to undertake more R&D initiatives

Amala Balakrishner
Amala Balakrishner • 2 min read
Hyphens Pharma gets a 'buy' from SAC as it looks to undertake more R&D initiatives
SAC Capital is maintaining its “buy” call and target price of 37 cents on pharmaceutical distributor Hyphens Pharma.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.